ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Neuroscience Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Published Date: October 2024
|
Report Code: QYRE-Auto-39P13391
Home | Market Reports | Science| Biological Sciences
Global Neuroscience Antibody Market Research Report 2023
BUY CHAPTERS

Neuroscience Antibody - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-39P13391
Report
October 2024
Pages:123
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Abcam
BioLegend
Bio-Rad Laboratories Inc
Cell Signaling Technology
Roche
Genscript Biotech Corp
Merck KGaA
Rockland Immunochemicals Inc.
Santa Cruz Biotechnology; Inc
Siemens Healthineers
Tecan Group Ltd
Thermo Fisher Scientific Inc
Enzo Life Sciences AG
Neobioscience

Neuroscience Antibody - Market Size

The global market for Neuroscience Antibody was estimated to be worth US$ 3370 million in 2023 and is forecast to a readjusted size of US$ 5633.8 million by 2030 with a CAGR of 7.7% during the forecast period 2024-2030

Neuroscience Antibody - Market

Neuroscience Antibody - Market

Neuroscience Antibodies are major tools to clarify the process and mechanism which take place during neural development and related disease. The key to neuroscience research is the identification of cellular, molecular and tissue features that can be used as biomarkers to help identify patients at risk for neurological disease and as targets for new therapies.
The global neuroscience antibody market refers to the market for antibodies used in neuroscience research and diagnostics. Antibodies are essential tools for studying the structure, function, and interactions of proteins in the brain and nervous system.
Neuroscience research plays a critical role in understanding the complexities of the brain and nervous system, as well as in developing effective treatments for neurological disorders and diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression. Antibodies are widely used in techniques such as immunohistochemistry, immunocytochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) for the detection and analysis of specific protein targets.
The market for neuroscience antibodies is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the growing elderly population worldwide are fueling the demand for research and diagnostic tools. Neuroscience antibodies play a fundamental role in identifying biomarkers, studying disease mechanisms, and developing targeted therapies.
Secondly, technological advancements in antibody development and conjugation techniques have expanded the range of applications and improved the specificity and sensitivity of neuroscience antibodies. This has led to increased adoption and demand for these antibodies in both academic and pharmaceutical research settings.
Thirdly, government and private funding initiatives aimed at promoting neuroscience research and drug discovery programs have further contributed to the growth of the neuroscience antibody market. Increased funding allows for more extensive research projects and the development of new antibodies targeting specific protein markers associated with neurological disorders.
The market for neuroscience antibodies is segmented based on the type of antibody, including monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are highly specific and are commonly used for targeted detection and analysis of protein markers. Polyclonal antibodies, on the other hand, exhibit a broader range of binding affinities and are often used for screening and initial characterization purposes.
Geographically, the market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has been a significant market for neuroscience antibodies due to the presence of well-established research institutions, pharmaceutical companies, and government support for neuroscience research. The Asia Pacific region is expected to witness significant market growth due to the increasing focus on neuroscience research and rising healthcare investments.
Key players in the global neuroscience antibody market include manufacturers specializing in antibody production, as well as biotechnology and pharmaceutical companies involved in neuroscience research and drug discovery. These companies offer a wide range of neuroscience antibodies targeting various protein markers and provide customization services to meet specific research needs. Collaboration with researchers and academia, as well as strategic mergers and acquisitions, are common strategies employed by key players to expand their market presence.
In summary, the global neuroscience antibody market is driven by factors such as the increasing prevalence of neurological disorders, technological advancements in antibody development, and research funding initiatives. Monoclonal and polyclonal antibodies are the two major types of antibodies used in neuroscience research. With ongoing advancements and the increasing focus on understanding the complexities of the brain, the neuroscience antibody market is expected to grow, providing valuable tools for researchers and contributing to advancements in neurological disease treatment and diagnostics.The global neuroscience antibody market refers to the market for antibodies used in neuroscience research and diagnostics. Antibodies are essential tools for studying the structure, function, and interactions of proteins in the brain and nervous system.
Neuroscience research plays a critical role in understanding the complexities of the brain and nervous system, as well as in developing effective treatments for neurological disorders and diseases such as Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and depression. Antibodies are widely used in techniques such as immunohistochemistry, immunocytochemistry, Western blotting, and enzyme-linked immunosorbent assay (ELISA) for the detection and analysis of specific protein targets.
The market for neuroscience antibodies is driven by several factors. Firstly, the increasing prevalence of neurological disorders and the growing elderly population worldwide are fueling the demand for research and diagnostic tools. Neuroscience antibodies play a fundamental role in identifying biomarkers, studying disease mechanisms, and developing targeted therapies.
Secondly, technological advancements in antibody development and conjugation techniques have expanded the range of applications and improved the specificity and sensitivity of neuroscience antibodies. This has led to increased adoption and demand for these antibodies in both academic and pharmaceutical research settings.
Thirdly, government and private funding initiatives aimed at promoting neuroscience research and drug discovery programs have further contributed to the growth of the neuroscience antibody market. Increased funding allows for more extensive research projects and the development of new antibodies targeting specific protein markers associated with neurological disorders.
The market for neuroscience antibodies is segmented based on the type of antibody, including monoclonal antibodies and polyclonal antibodies. Monoclonal antibodies are highly specific and are commonly used for targeted detection and analysis of protein markers. Polyclonal antibodies, on the other hand, exhibit a broader range of binding affinities and are often used for screening and initial characterization purposes.
Geographically, the market is divided into regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America has been a significant market for neuroscience antibodies due to the presence of well-established research institutions, pharmaceutical companies, and government support for neuroscience research. The Asia Pacific region is expected to witness significant market growth due to the increasing focus on neuroscience research and rising healthcare investments.
Key players in the global neuroscience antibody market include manufacturers specializing in antibody production, as well as biotechnology and pharmaceutical companies involved in neuroscience research and drug discovery. These companies offer a wide range of neuroscience antibodies targeting various protein markers and provide customization services to meet specific research needs. Collaboration with researchers and academia, as well as strategic mergers and acquisitions, are common strategies employed by key players to expand their market presence.
In summary, the global neuroscience antibody market is driven by factors such as the increasing prevalence of neurological disorders, technological advancements in antibody development, and research funding initiatives. Monoclonal and polyclonal antibodies are the two major types of antibodies used in neuroscience research. With ongoing advancements and the increasing focus on understanding the complexities of the brain, the neuroscience antibody market is expected to grow, providing valuable tools for researchers and contributing to advancements in neurological disease treatment and diagnostics.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Neuroscience Antibody, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Neuroscience Antibody by region & country, by Type, and by Application.
The Neuroscience Antibody market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Neuroscience Antibody.
Market Segmentation

Scope of Neuroscience Antibody - Market Report

Report Metric Details
Report Name Neuroscience Antibody - Market
Forecasted market size in 2030 US$ 5633.8 million
CAGR 7.7%
Forecasted years 2024 - 2030
Segment by Type:
  • Antibodies
  • Research Reagents
Segment by Application
  • Hospitals and Diagnostics Centers
  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abcam, BioLegend, Bio-Rad Laboratories Inc, Cell Signaling Technology, Roche, Genscript Biotech Corp, Merck KGaA, Rockland Immunochemicals Inc, Santa Cruz Biotechnology Inc, Siemens Healthineers, Tecan Group Ltd, Thermo Fisher Scientific Inc, Enzo Life Sciences AG, Neobioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 2: Detailed analysis of Neuroscience Antibody manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 5: Sales, revenue of Neuroscience Antibody in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 6: Sales, revenue of Neuroscience Antibody in country level. It provides sigmate data by Type, and by Application for each country/region.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Conclusion.

FAQ for this report

What is the Neuroscience Antibody - Market size in 2030?

Ans: The Neuroscience Antibody - Market size in 2030 will be US$ 5633.8 million.

Who are the main players in the Neuroscience Antibody - Market report?

Ans: The main players in the Neuroscience Antibody - Market are Abcam, BioLegend, Bio-Rad Laboratories Inc, Cell Signaling Technology, Roche, Genscript Biotech Corp, Merck KGaA, Rockland Immunochemicals Inc, Santa Cruz Biotechnology Inc, Siemens Healthineers, Tecan Group Ltd, Thermo Fisher Scientific Inc, Enzo Life Sciences AG, Neobioscience

What are the Application segmentation covered in the Neuroscience Antibody - Market report?

Ans: The Applications covered in the Neuroscience Antibody - Market report are Hospitals and Diagnostics Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies

What are the Type segmentation covered in the Neuroscience Antibody - Market report?

Ans: The Types covered in the Neuroscience Antibody - Market report are Antibodies, Research Reagents

1 Market Overview
1.1 Neuroscience Antibody Product Introduction
1.2 Global Neuroscience Antibody Market Size Forecast
1.2.1 Global Neuroscience Antibody Sales Value (2019-2030)
1.2.2 Global Neuroscience Antibody Sales Volume (2019-2030)
1.2.3 Global Neuroscience Antibody Sales Price (2019-2030)
1.3 Neuroscience Antibody Market Trends & Drivers
1.3.1 Neuroscience Antibody Industry Trends
1.3.2 Neuroscience Antibody Market Drivers & Opportunity
1.3.3 Neuroscience Antibody Market Challenges
1.3.4 Neuroscience Antibody Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Neuroscience Antibody Players Revenue Ranking (2023)
2.2 Global Neuroscience Antibody Revenue by Company (2019-2024)
2.3 Global Neuroscience Antibody Players Sales Volume Ranking (2023)
2.4 Global Neuroscience Antibody Sales Volume by Company Players (2019-2024)
2.5 Global Neuroscience Antibody Average Price by Company (2019-2024)
2.6 Key Manufacturers Neuroscience Antibody Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Neuroscience Antibody Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Neuroscience Antibody
2.9 Neuroscience Antibody Market Competitive Analysis
2.9.1 Neuroscience Antibody Market Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Neuroscience Antibody Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibody as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Antibodies
3.1.2 Research Reagents
3.2 Global Neuroscience Antibody Sales Value by Type
3.2.1 Global Neuroscience Antibody Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Neuroscience Antibody Sales Value, by Type (2019-2030)
3.2.3 Global Neuroscience Antibody Sales Value, by Type (%) (2019-2030)
3.3 Global Neuroscience Antibody Sales Volume by Type
3.3.1 Global Neuroscience Antibody Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Neuroscience Antibody Sales Volume, by Type (2019-2030)
3.3.3 Global Neuroscience Antibody Sales Volume, by Type (%) (2019-2030)
3.4 Global Neuroscience Antibody Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Hospitals and Diagnostics Centers
4.1.2 Academic and Research Institutes
4.1.3 Pharmaceutical and Biotechnology Companies
4.2 Global Neuroscience Antibody Sales Value by Application
4.2.1 Global Neuroscience Antibody Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Neuroscience Antibody Sales Value, by Application (2019-2030)
4.2.3 Global Neuroscience Antibody Sales Value, by Application (%) (2019-2030)
4.3 Global Neuroscience Antibody Sales Volume by Application
4.3.1 Global Neuroscience Antibody Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Neuroscience Antibody Sales Volume, by Application (2019-2030)
4.3.3 Global Neuroscience Antibody Sales Volume, by Application (%) (2019-2030)
4.4 Global Neuroscience Antibody Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Neuroscience Antibody Sales Value by Region
5.1.1 Global Neuroscience Antibody Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Neuroscience Antibody Sales Value by Region (2019-2024)
5.1.3 Global Neuroscience Antibody Sales Value by Region (2025-2030)
5.1.4 Global Neuroscience Antibody Sales Value by Region (%), (2019-2030)
5.2 Global Neuroscience Antibody Sales Volume by Region
5.2.1 Global Neuroscience Antibody Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Neuroscience Antibody Sales Volume by Region (2019-2024)
5.2.3 Global Neuroscience Antibody Sales Volume by Region (2025-2030)
5.2.4 Global Neuroscience Antibody Sales Volume by Region (%), (2019-2030)
5.3 Global Neuroscience Antibody Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Neuroscience Antibody Sales Value, 2019-2030
5.4.2 North America Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Neuroscience Antibody Sales Value, 2019-2030
5.5.2 Europe Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Neuroscience Antibody Sales Value, 2019-2030
5.6.2 Asia Pacific Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Neuroscience Antibody Sales Value, 2019-2030
5.7.2 South America Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Neuroscience Antibody Sales Value, 2019-2030
5.8.2 Middle East & Africa Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Neuroscience Antibody Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Neuroscience Antibody Sales Value
6.2.1 Key Countries/Regions Neuroscience Antibody Sales Value, 2019-2030
6.2.2 Key Countries/Regions Neuroscience Antibody Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Neuroscience Antibody Sales Value, 2019-2030
6.3.2 United States Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Neuroscience Antibody Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Neuroscience Antibody Sales Value, 2019-2030
6.4.2 Europe Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Neuroscience Antibody Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Neuroscience Antibody Sales Value, 2019-2030
6.5.2 China Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
6.5.3 China Neuroscience Antibody Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Neuroscience Antibody Sales Value, 2019-2030
6.6.2 Japan Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Neuroscience Antibody Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Neuroscience Antibody Sales Value, 2019-2030
6.7.2 South Korea Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Neuroscience Antibody Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Neuroscience Antibody Sales Value, 2019-2030
6.8.2 Southeast Asia Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Neuroscience Antibody Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Neuroscience Antibody Sales Value, 2019-2030
6.9.2 India Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
6.9.3 India Neuroscience Antibody Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Abcam
7.1.1 Abcam Company Information
7.1.2 Abcam Introduction and Business Overview
7.1.3 Abcam Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Abcam Neuroscience Antibody Product Offerings
7.1.5 Abcam Recent Development
7.2 BioLegend
7.2.1 BioLegend Company Information
7.2.2 BioLegend Introduction and Business Overview
7.2.3 BioLegend Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.2.4 BioLegend Neuroscience Antibody Product Offerings
7.2.5 BioLegend Recent Development
7.3 Bio-Rad Laboratories Inc
7.3.1 Bio-Rad Laboratories Inc Company Information
7.3.2 Bio-Rad Laboratories Inc Introduction and Business Overview
7.3.3 Bio-Rad Laboratories Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Bio-Rad Laboratories Inc Neuroscience Antibody Product Offerings
7.3.5 Bio-Rad Laboratories Inc Recent Development
7.4 Cell Signaling Technology
7.4.1 Cell Signaling Technology Company Information
7.4.2 Cell Signaling Technology Introduction and Business Overview
7.4.3 Cell Signaling Technology Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Cell Signaling Technology Neuroscience Antibody Product Offerings
7.4.5 Cell Signaling Technology Recent Development
7.5 Roche
7.5.1 Roche Company Information
7.5.2 Roche Introduction and Business Overview
7.5.3 Roche Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Roche Neuroscience Antibody Product Offerings
7.5.5 Roche Recent Development
7.6 Genscript Biotech Corp
7.6.1 Genscript Biotech Corp Company Information
7.6.2 Genscript Biotech Corp Introduction and Business Overview
7.6.3 Genscript Biotech Corp Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Genscript Biotech Corp Neuroscience Antibody Product Offerings
7.6.5 Genscript Biotech Corp Recent Development
7.7 Merck KGaA
7.7.1 Merck KGaA Company Information
7.7.2 Merck KGaA Introduction and Business Overview
7.7.3 Merck KGaA Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Merck KGaA Neuroscience Antibody Product Offerings
7.7.5 Merck KGaA Recent Development
7.8 Rockland Immunochemicals Inc
7.8.1 Rockland Immunochemicals Inc Company Information
7.8.2 Rockland Immunochemicals Inc Introduction and Business Overview
7.8.3 Rockland Immunochemicals Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Rockland Immunochemicals Inc Neuroscience Antibody Product Offerings
7.8.5 Rockland Immunochemicals Inc Recent Development
7.9 Santa Cruz Biotechnology Inc
7.9.1 Santa Cruz Biotechnology Inc Company Information
7.9.2 Santa Cruz Biotechnology Inc Introduction and Business Overview
7.9.3 Santa Cruz Biotechnology Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.9.4 Santa Cruz Biotechnology Inc Neuroscience Antibody Product Offerings
7.9.5 Santa Cruz Biotechnology Inc Recent Development
7.10 Siemens Healthineers
7.10.1 Siemens Healthineers Company Information
7.10.2 Siemens Healthineers Introduction and Business Overview
7.10.3 Siemens Healthineers Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.10.4 Siemens Healthineers Neuroscience Antibody Product Offerings
7.10.5 Siemens Healthineers Recent Development
7.11 Tecan Group Ltd
7.11.1 Tecan Group Ltd Company Information
7.11.2 Tecan Group Ltd Introduction and Business Overview
7.11.3 Tecan Group Ltd Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.11.4 Tecan Group Ltd Neuroscience Antibody Product Offerings
7.11.5 Tecan Group Ltd Recent Development
7.12 Thermo Fisher Scientific Inc
7.12.1 Thermo Fisher Scientific Inc Company Information
7.12.2 Thermo Fisher Scientific Inc Introduction and Business Overview
7.12.3 Thermo Fisher Scientific Inc Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.12.4 Thermo Fisher Scientific Inc Neuroscience Antibody Product Offerings
7.12.5 Thermo Fisher Scientific Inc Recent Development
7.13 Enzo Life Sciences AG
7.13.1 Enzo Life Sciences AG Company Information
7.13.2 Enzo Life Sciences AG Introduction and Business Overview
7.13.3 Enzo Life Sciences AG Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.13.4 Enzo Life Sciences AG Neuroscience Antibody Product Offerings
7.13.5 Enzo Life Sciences AG Recent Development
7.14 Neobioscience
7.14.1 Neobioscience Company Information
7.14.2 Neobioscience Introduction and Business Overview
7.14.3 Neobioscience Neuroscience Antibody Sales, Revenue and Gross Margin (2019-2024)
7.14.4 Neobioscience Neuroscience Antibody Product Offerings
7.14.5 Neobioscience Recent Development
8 Industry Chain Analysis
8.1 Neuroscience Antibody Industrial Chain
8.2 Neuroscience Antibody Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Neuroscience Antibody Sales Model
8.5.2 Sales Channel
8.5.3 Neuroscience Antibody Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
FEATURED COMPANIES
Abcam
BioLegend
Bio-Rad Laboratories Inc
Cell Signaling Technology
Roche
Genscript Biotech Corp
Merck KGaA
Rockland Immunochemicals Inc.
Santa Cruz Biotechnology; Inc
Siemens Healthineers
Tecan Group Ltd
Thermo Fisher Scientific Inc
Enzo Life Sciences AG
Neobioscience
List of Tables
    Table 1. Neuroscience Antibody Market Trends
    Table 2. Neuroscience Antibody Market Drivers & Opportunity
    Table 3. Neuroscience Antibody Market Challenges
    Table 4. Neuroscience Antibody Market Restraints
    Table 5. Global Neuroscience Antibody Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Neuroscience Antibody Revenue Market Share by Company (2019-2024)
    Table 7. Global Neuroscience Antibody Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Neuroscience Antibody Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Neuroscience Antibody Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Neuroscience Antibody Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Neuroscience Antibody Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Neuroscience Antibody
    Table 13. Global Neuroscience Antibody Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neuroscience Antibody as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Neuroscience Antibody Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Neuroscience Antibody Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Neuroscience Antibody Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Neuroscience Antibody Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Neuroscience Antibody Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Neuroscience Antibody Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Neuroscience Antibody Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Neuroscience Antibody Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Neuroscience Antibody Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Neuroscience Antibody Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Neuroscience Antibody Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Neuroscience Antibody Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Neuroscience Antibody Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Neuroscience Antibody Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Neuroscience Antibody Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Neuroscience Antibody Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Neuroscience Antibody Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Neuroscience Antibody Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Neuroscience Antibody Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Neuroscience Antibody Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Neuroscience Antibody Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Neuroscience Antibody Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Neuroscience Antibody Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Neuroscience Antibody Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Neuroscience Antibody Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Neuroscience Antibody Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Neuroscience Antibody Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Neuroscience Antibody Sales Value by Region (2019-2024) & (%)
    Table 44. Global Neuroscience Antibody Sales Value by Region (2025-2030) & (%)
    Table 45. Global Neuroscience Antibody Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Neuroscience Antibody Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Neuroscience Antibody Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Neuroscience Antibody Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Neuroscience Antibody Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Neuroscience Antibody Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Neuroscience Antibody Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Neuroscience Antibody Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Neuroscience Antibody Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Neuroscience Antibody Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Neuroscience Antibody Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Neuroscience Antibody Sales Volume, (2025-2030) & (K Units)
    Table 57. Abcam Company Information
    Table 58. Abcam Introduction and Business Overview
    Table 59. Abcam Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Abcam Neuroscience Antibody Product Offerings
    Table 61. Abcam Recent Development
    Table 62. BioLegend Company Information
    Table 63. BioLegend Introduction and Business Overview
    Table 64. BioLegend Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. BioLegend Neuroscience Antibody Product Offerings
    Table 66. BioLegend Recent Development
    Table 67. Bio-Rad Laboratories Inc Company Information
    Table 68. Bio-Rad Laboratories Inc Introduction and Business Overview
    Table 69. Bio-Rad Laboratories Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. Bio-Rad Laboratories Inc Neuroscience Antibody Product Offerings
    Table 71. Bio-Rad Laboratories Inc Recent Development
    Table 72. Cell Signaling Technology Company Information
    Table 73. Cell Signaling Technology Introduction and Business Overview
    Table 74. Cell Signaling Technology Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Cell Signaling Technology Neuroscience Antibody Product Offerings
    Table 76. Cell Signaling Technology Recent Development
    Table 77. Roche Company Information
    Table 78. Roche Introduction and Business Overview
    Table 79. Roche Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Roche Neuroscience Antibody Product Offerings
    Table 81. Roche Recent Development
    Table 82. Genscript Biotech Corp Company Information
    Table 83. Genscript Biotech Corp Introduction and Business Overview
    Table 84. Genscript Biotech Corp Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Genscript Biotech Corp Neuroscience Antibody Product Offerings
    Table 86. Genscript Biotech Corp Recent Development
    Table 87. Merck KGaA Company Information
    Table 88. Merck KGaA Introduction and Business Overview
    Table 89. Merck KGaA Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Merck KGaA Neuroscience Antibody Product Offerings
    Table 91. Merck KGaA Recent Development
    Table 92. Rockland Immunochemicals Inc Company Information
    Table 93. Rockland Immunochemicals Inc Introduction and Business Overview
    Table 94. Rockland Immunochemicals Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Rockland Immunochemicals Inc Neuroscience Antibody Product Offerings
    Table 96. Rockland Immunochemicals Inc Recent Development
    Table 97. Santa Cruz Biotechnology Inc Company Information
    Table 98. Santa Cruz Biotechnology Inc Introduction and Business Overview
    Table 99. Santa Cruz Biotechnology Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Santa Cruz Biotechnology Inc Neuroscience Antibody Product Offerings
    Table 101. Santa Cruz Biotechnology Inc Recent Development
    Table 102. Siemens Healthineers Company Information
    Table 103. Siemens Healthineers Introduction and Business Overview
    Table 104. Siemens Healthineers Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 105. Siemens Healthineers Neuroscience Antibody Product Offerings
    Table 106. Siemens Healthineers Recent Development
    Table 107. Tecan Group Ltd Company Information
    Table 108. Tecan Group Ltd Introduction and Business Overview
    Table 109. Tecan Group Ltd Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 110. Tecan Group Ltd Neuroscience Antibody Product Offerings
    Table 111. Tecan Group Ltd Recent Development
    Table 112. Thermo Fisher Scientific Inc Company Information
    Table 113. Thermo Fisher Scientific Inc Introduction and Business Overview
    Table 114. Thermo Fisher Scientific Inc Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 115. Thermo Fisher Scientific Inc Neuroscience Antibody Product Offerings
    Table 116. Thermo Fisher Scientific Inc Recent Development
    Table 117. Enzo Life Sciences AG Company Information
    Table 118. Enzo Life Sciences AG Introduction and Business Overview
    Table 119. Enzo Life Sciences AG Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 120. Enzo Life Sciences AG Neuroscience Antibody Product Offerings
    Table 121. Enzo Life Sciences AG Recent Development
    Table 122. Neobioscience Company Information
    Table 123. Neobioscience Introduction and Business Overview
    Table 124. Neobioscience Neuroscience Antibody Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 125. Neobioscience Neuroscience Antibody Product Offerings
    Table 126. Neobioscience Recent Development
    Table 127. Key Raw Materials Lists
    Table 128. Raw Materials Key Suppliers Lists
    Table 129. Neuroscience Antibody Downstream Customers
    Table 130. Neuroscience Antibody Distributors List
    Table 131. Research Programs/Design for This Report
    Table 132. Key Data Information from Secondary Sources
    Table 133. Key Data Information from Primary Sources
List of Figures
    Figure 1. Neuroscience Antibody Product Picture
    Figure 2. Global Neuroscience Antibody Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Neuroscience Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Neuroscience Antibody Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Neuroscience Antibody Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Neuroscience Antibody Report Years Considered
    Figure 7. Global Neuroscience Antibody Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Neuroscience Antibody Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Neuroscience Antibody Revenue in 2023
    Figure 10. Neuroscience Antibody Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Antibodies Picture
    Figure 12. Research Reagents Picture
    Figure 13. Global Neuroscience Antibody Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 14. Global Neuroscience Antibody Sales Value Market Share by Type, 2023 & 2030
    Figure 15. Global Neuroscience Antibody Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 16. Global Neuroscience Antibody Sales Volume Market Share by Type, 2023 & 2030
    Figure 17. Global Neuroscience Antibody Price by Type (2019-2030) & (US$/Unit)
    Figure 18. Product Picture of Hospitals and Diagnostics Centers
    Figure 19. Product Picture of Academic and Research Institutes
    Figure 20. Product Picture of Pharmaceutical and Biotechnology Companies
    Figure 21. Global Neuroscience Antibody Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 22. Global Neuroscience Antibody Sales Value Market Share by Application, 2023 & 2030
    Figure 23. Global Neuroscience Antibody Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 24. Global Neuroscience Antibody Sales Volume Market Share by Application, 2023 & 2030
    Figure 25. Global Neuroscience Antibody Price by Application (2019-2030) & (US$/Unit)
    Figure 26. North America Neuroscience Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 27. North America Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 28. Europe Neuroscience Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 29. Europe Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 30. Asia Pacific Neuroscience Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 31. Asia Pacific Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 32. South America Neuroscience Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 33. South America Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 34. Middle East & Africa Neuroscience Antibody Sales Value (2019-2030) & (US$ Million)
    Figure 35. Middle East & Africa Neuroscience Antibody Sales Value by Country (%), 2023 VS 2030
    Figure 36. Key Countries/Regions Neuroscience Antibody Sales Value (%), (2019-2030)
    Figure 37. Key Countries/Regions Neuroscience Antibody Sales Volume (%), (2019-2030)
    Figure 38. United States Neuroscience Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 39. United States Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 40. United States Neuroscience Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 41. Europe Neuroscience Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 42. Europe Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 43. Europe Neuroscience Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 44. China Neuroscience Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 45. China Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 46. China Neuroscience Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 47. Japan Neuroscience Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 48. Japan Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 49. Japan Neuroscience Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 50. South Korea Neuroscience Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 51. South Korea Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 52. South Korea Neuroscience Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 53. Southeast Asia Neuroscience Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 54. Southeast Asia Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 55. Southeast Asia Neuroscience Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 56. India Neuroscience Antibody Sales Value, (2019-2030) & (US$ Million)
    Figure 57. India Neuroscience Antibody Sales Value by Type (%), 2023 VS 2030
    Figure 58. India Neuroscience Antibody Sales Value by Application (%), 2023 VS 2030
    Figure 59. Neuroscience Antibody Industrial Chain
    Figure 60. Neuroscience Antibody Manufacturing Cost Structure
    Figure 61. Channels of Distribution (Direct Sales, and Distribution)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$3950

This license allows only one user to access the PDF.
Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SecuX Technology Inc

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions